omniabio inc. is bringing life-saving cell and gene therapies to patients around the world.
omniabio inc., a subsidiary of ccrm, launched july 1, 2022. omniabio is a contract development and manufacturing organization (cdmo) conducting process development and producing gene-modified cells and viral vectors for phase i clinical trials to commercial-scale manufacturing. omniabio is bringing life-saving cell and gene therapies to patients in canada and around the world.